1-169378417-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001320973.2(BLZF1):c.556C>G(p.Gln186Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001320973.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BLZF1 | ENST00000367808.8 | c.556C>G | p.Gln186Glu | missense_variant | Exon 4 of 7 | 1 | NM_001320973.2 | ENSP00000356782.3 | ||
BLZF1 | ENST00000329281.6 | c.556C>G | p.Gln186Glu | missense_variant | Exon 4 of 8 | 1 | ENSP00000327541.2 | |||
BLZF1 | ENST00000426663.1 | c.556C>G | p.Gln186Glu | missense_variant | Exon 4 of 5 | 3 | ENSP00000404408.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.556C>G (p.Q186E) alteration is located in exon 4 (coding exon 3) of the BLZF1 gene. This alteration results from a C to G substitution at nucleotide position 556, causing the glutamine (Q) at amino acid position 186 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at